Report Detail
Global Dihydroartemisinin Tablets Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032
- RnM4770144 |
- 06 November, 2026 |
- Global |
- 86 Pages |
- GIR |
- Pharma & Healthcare
According to our (Global Info Research) latest study, the global Dihydroartemisinin Tablets market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
Dihydroartemisinin tablets are a type of medication used primarily for the treatment of malaria. Dihydroartemisinin (DHA) is a potent antimalarial agent derived from artemisinin, a compound extracted from the sweet wormwood plant (Artemisia annua).
This report is a detailed and comprehensive analysis for global Dihydroartemisinin Tablets market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Dihydroartemisinin Tablets market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Dihydroartemisinin Tablets market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Dihydroartemisinin Tablets market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Dihydroartemisinin Tablets market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Dihydroartemisinin Tablets
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Dihydroartemisinin Tablets market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include KPC Pharmaceuticals, Guilin Nantang Pharmaceutical, Ipca Laboratories, AdvaCare Pharma, Centurion Healthcare, Schwitz Biotech, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Dihydroartemisinin Tablets market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Compound Dihydroartemisinin
Single Dihydroartemisinin
Market segment by Application
Hospital Pharmacy
Retail Pharmacy
Major players covered
KPC Pharmaceuticals
Guilin Nantang Pharmaceutical
Ipca Laboratories
AdvaCare Pharma
Centurion Healthcare
Schwitz Biotech
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Dihydroartemisinin Tablets product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Dihydroartemisinin Tablets, with price, sales quantity, revenue, and global market share of Dihydroartemisinin Tablets from 2021 to 2026.
Chapter 3, the Dihydroartemisinin Tablets competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Dihydroartemisinin Tablets breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Dihydroartemisinin Tablets market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Dihydroartemisinin Tablets.
Chapter 14 and 15, to describe Dihydroartemisinin Tablets sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
- 1.1 Product Overview and Scope
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Market Analysis by Type
- 1.3.1 Overview: Global Dihydroartemisinin Tablets Consumption Value by Type: 2021 Versus 2025 Versus 2032
- 1.3.2 Compound Dihydroartemisinin
- 1.3.3 Single Dihydroartemisinin
- 1.4 Market Analysis by Application
- 1.4.1 Overview: Global Dihydroartemisinin Tablets Consumption Value by Application: 2021 Versus 2025 Versus 2032
- 1.4.2 Hospital Pharmacy
- 1.4.3 Retail Pharmacy
- 1.5 Global Dihydroartemisinin Tablets Market Size & Forecast
- 1.5.1 Global Dihydroartemisinin Tablets Consumption Value (2021 & 2025 & 2032)
- 1.5.2 Global Dihydroartemisinin Tablets Sales Quantity (2021-2032)
- 1.5.3 Global Dihydroartemisinin Tablets Average Price (2021-2032)
2 Manufacturers Profiles
- 2.1 KPC Pharmaceuticals
- 2.1.1 KPC Pharmaceuticals Details
- 2.1.2 KPC Pharmaceuticals Major Business
- 2.1.3 KPC Pharmaceuticals Dihydroartemisinin Tablets Product and Services
- 2.1.4 KPC Pharmaceuticals Dihydroartemisinin Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.1.5 KPC Pharmaceuticals Recent Developments/Updates
- 2.2 Guilin Nantang Pharmaceutical
- 2.2.1 Guilin Nantang Pharmaceutical Details
- 2.2.2 Guilin Nantang Pharmaceutical Major Business
- 2.2.3 Guilin Nantang Pharmaceutical Dihydroartemisinin Tablets Product and Services
- 2.2.4 Guilin Nantang Pharmaceutical Dihydroartemisinin Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.2.5 Guilin Nantang Pharmaceutical Recent Developments/Updates
- 2.3 Ipca Laboratories
- 2.3.1 Ipca Laboratories Details
- 2.3.2 Ipca Laboratories Major Business
- 2.3.3 Ipca Laboratories Dihydroartemisinin Tablets Product and Services
- 2.3.4 Ipca Laboratories Dihydroartemisinin Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.3.5 Ipca Laboratories Recent Developments/Updates
- 2.4 AdvaCare Pharma
- 2.4.1 AdvaCare Pharma Details
- 2.4.2 AdvaCare Pharma Major Business
- 2.4.3 AdvaCare Pharma Dihydroartemisinin Tablets Product and Services
- 2.4.4 AdvaCare Pharma Dihydroartemisinin Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.4.5 AdvaCare Pharma Recent Developments/Updates
- 2.5 Centurion Healthcare
- 2.5.1 Centurion Healthcare Details
- 2.5.2 Centurion Healthcare Major Business
- 2.5.3 Centurion Healthcare Dihydroartemisinin Tablets Product and Services
- 2.5.4 Centurion Healthcare Dihydroartemisinin Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.5.5 Centurion Healthcare Recent Developments/Updates
- 2.6 Schwitz Biotech
- 2.6.1 Schwitz Biotech Details
- 2.6.2 Schwitz Biotech Major Business
- 2.6.3 Schwitz Biotech Dihydroartemisinin Tablets Product and Services
- 2.6.4 Schwitz Biotech Dihydroartemisinin Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.6.5 Schwitz Biotech Recent Developments/Updates
3 Competitive Environment: Dihydroartemisinin Tablets by Manufacturer
- 3.1 Global Dihydroartemisinin Tablets Sales Quantity by Manufacturer (2021-2026)
- 3.2 Global Dihydroartemisinin Tablets Revenue by Manufacturer (2021-2026)
- 3.3 Global Dihydroartemisinin Tablets Average Price by Manufacturer (2021-2026)
- 3.4 Market Share Analysis (2025)
- 3.4.1 Producer Shipments of Dihydroartemisinin Tablets by Manufacturer Revenue ($MM) and Market Share (%): 2025
- 3.4.2 Top 3 Dihydroartemisinin Tablets Manufacturer Market Share in 2025
- 3.4.3 Top 6 Dihydroartemisinin Tablets Manufacturer Market Share in 2025
- 3.5 Dihydroartemisinin Tablets Market: Overall Company Footprint Analysis
- 3.5.1 Dihydroartemisinin Tablets Market: Region Footprint
- 3.5.2 Dihydroartemisinin Tablets Market: Company Product Type Footprint
- 3.5.3 Dihydroartemisinin Tablets Market: Company Product Application Footprint
- 3.6 New Market Entrants and Barriers to Market Entry
- 3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
- 4.1 Global Dihydroartemisinin Tablets Market Size by Region
- 4.1.1 Global Dihydroartemisinin Tablets Sales Quantity by Region (2021-2032)
- 4.1.2 Global Dihydroartemisinin Tablets Consumption Value by Region (2021-2032)
- 4.1.3 Global Dihydroartemisinin Tablets Average Price by Region (2021-2032)
- 4.2 North America Dihydroartemisinin Tablets Consumption Value (2021-2032)
- 4.3 Europe Dihydroartemisinin Tablets Consumption Value (2021-2032)
- 4.4 Asia-Pacific Dihydroartemisinin Tablets Consumption Value (2021-2032)
- 4.5 South America Dihydroartemisinin Tablets Consumption Value (2021-2032)
- 4.6 Middle East & Africa Dihydroartemisinin Tablets Consumption Value (2021-2032)
5 Market Segment by Type
- 5.1 Global Dihydroartemisinin Tablets Sales Quantity by Type (2021-2032)
- 5.2 Global Dihydroartemisinin Tablets Consumption Value by Type (2021-2032)
- 5.3 Global Dihydroartemisinin Tablets Average Price by Type (2021-2032)
6 Market Segment by Application
- 6.1 Global Dihydroartemisinin Tablets Sales Quantity by Application (2021-2032)
- 6.2 Global Dihydroartemisinin Tablets Consumption Value by Application (2021-2032)
- 6.3 Global Dihydroartemisinin Tablets Average Price by Application (2021-2032)
7 North America
- 7.1 North America Dihydroartemisinin Tablets Sales Quantity by Type (2021-2032)
- 7.2 North America Dihydroartemisinin Tablets Sales Quantity by Application (2021-2032)
- 7.3 North America Dihydroartemisinin Tablets Market Size by Country
- 7.3.1 North America Dihydroartemisinin Tablets Sales Quantity by Country (2021-2032)
- 7.3.2 North America Dihydroartemisinin Tablets Consumption Value by Country (2021-2032)
- 7.3.3 United States Market Size and Forecast (2021-2032)
- 7.3.4 Canada Market Size and Forecast (2021-2032)
- 7.3.5 Mexico Market Size and Forecast (2021-2032)
8 Europe
- 8.1 Europe Dihydroartemisinin Tablets Sales Quantity by Type (2021-2032)
- 8.2 Europe Dihydroartemisinin Tablets Sales Quantity by Application (2021-2032)
- 8.3 Europe Dihydroartemisinin Tablets Market Size by Country
- 8.3.1 Europe Dihydroartemisinin Tablets Sales Quantity by Country (2021-2032)
- 8.3.2 Europe Dihydroartemisinin Tablets Consumption Value by Country (2021-2032)
- 8.3.3 Germany Market Size and Forecast (2021-2032)
- 8.3.4 France Market Size and Forecast (2021-2032)
- 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
- 8.3.6 Russia Market Size and Forecast (2021-2032)
- 8.3.7 Italy Market Size and Forecast (2021-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Dihydroartemisinin Tablets Sales Quantity by Type (2021-2032)
- 9.2 Asia-Pacific Dihydroartemisinin Tablets Sales Quantity by Application (2021-2032)
- 9.3 Asia-Pacific Dihydroartemisinin Tablets Market Size by Region
- 9.3.1 Asia-Pacific Dihydroartemisinin Tablets Sales Quantity by Region (2021-2032)
- 9.3.2 Asia-Pacific Dihydroartemisinin Tablets Consumption Value by Region (2021-2032)
- 9.3.3 China Market Size and Forecast (2021-2032)
- 9.3.4 Japan Market Size and Forecast (2021-2032)
- 9.3.5 South Korea Market Size and Forecast (2021-2032)
- 9.3.6 India Market Size and Forecast (2021-2032)
- 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
- 9.3.8 Australia Market Size and Forecast (2021-2032)
10 South America
- 10.1 South America Dihydroartemisinin Tablets Sales Quantity by Type (2021-2032)
- 10.2 South America Dihydroartemisinin Tablets Sales Quantity by Application (2021-2032)
- 10.3 South America Dihydroartemisinin Tablets Market Size by Country
- 10.3.1 South America Dihydroartemisinin Tablets Sales Quantity by Country (2021-2032)
- 10.3.2 South America Dihydroartemisinin Tablets Consumption Value by Country (2021-2032)
- 10.3.3 Brazil Market Size and Forecast (2021-2032)
- 10.3.4 Argentina Market Size and Forecast (2021-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Dihydroartemisinin Tablets Sales Quantity by Type (2021-2032)
- 11.2 Middle East & Africa Dihydroartemisinin Tablets Sales Quantity by Application (2021-2032)
- 11.3 Middle East & Africa Dihydroartemisinin Tablets Market Size by Country
- 11.3.1 Middle East & Africa Dihydroartemisinin Tablets Sales Quantity by Country (2021-2032)
- 11.3.2 Middle East & Africa Dihydroartemisinin Tablets Consumption Value by Country (2021-2032)
- 11.3.3 Turkey Market Size and Forecast (2021-2032)
- 11.3.4 Egypt Market Size and Forecast (2021-2032)
- 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
- 11.3.6 South Africa Market Size and Forecast (2021-2032)
12 Market Dynamics
- 12.1 Dihydroartemisinin Tablets Market Drivers
- 12.2 Dihydroartemisinin Tablets Market Restraints
- 12.3 Dihydroartemisinin Tablets Trends Analysis
- 12.4 Porters Five Forces Analysis
- 12.4.1 Threat of New Entrants
- 12.4.2 Bargaining Power of Suppliers
- 12.4.3 Bargaining Power of Buyers
- 12.4.4 Threat of Substitutes
- 12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
- 13.1 Raw Material of Dihydroartemisinin Tablets and Key Manufacturers
- 13.2 Manufacturing Costs Percentage of Dihydroartemisinin Tablets
- 13.3 Dihydroartemisinin Tablets Production Process
- 13.4 Industry Value Chain Analysis
14 Shipments by Distribution Channel
- 14.1 Sales Channel
- 14.1.1 Direct to End-User
- 14.1.2 Distributors
- 14.2 Dihydroartemisinin Tablets Typical Distributors
- 14.3 Dihydroartemisinin Tablets Typical Customers
15 Research Findings and Conclusion
16 Appendix
- 16.1 Methodology
- 16.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on Dihydroartemisinin Tablets. Industry analysis & Market Report on Dihydroartemisinin Tablets is a syndicated market report, published as Global Dihydroartemisinin Tablets Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Dihydroartemisinin Tablets market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
